Evidence map›Paper›PMID 29804104›Full record

ReviewNeonatology2018

New Threats from an Old Foe: Methicillin-Resistant Staphylococcus aureus Infections in Neonates.

Ying Dong, Kirsten Glaser, Christian P Speer

Open access · hybridAbstract readReview
In one paragraph

Review in Neonatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Multidrug-Resistant Methicillin-ResistantDiagnostics (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Neonatal Staphylococcus Aureus Sepsis: a 20-year Western Australian experience.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
  16. Reducing Staphylococcus aureus infections in the neonatal intensive care unit.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Ying DongUniversity Children's Hospital, University of Würzburg, Würzburg, Germany.
Kirsten GlaserUniversity Children's Hospital, University of Würzburg, Würzburg, Germany.
Christian P SpeerUniversity Children's Hospital, University of Würzburg, Würzburg, Germany.
University of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a ubiquitous human inhabitant and one of the important pathogens of neonatal infections. MRSA is associated with significant mortality and morbidity, especially in very immature preterm neonates. Moreover, MRSA may be implicated in adverse long-term neonatal outcomes, posing a substantial disease burden. Recent advances in molecular microbiology have shed light on the evolution of MRSA population structure and virulence factors, which may contribute to MRSA epidemic waves worldwide. Equipped with remarkable genetic flexibility, MRSA has successfully developed resistance to an extensive range of antibiotics including vancomycin, as well as antiseptics. In the face of these new challenges from MRSA, our armamentarium of anti-infective strategies is very limited and largely dependent on prevention measures. Active surveillance cultures followed by decolonization may be a promising approach to control MRSA infections, with its efficacy and safety in the specific population of neonates yet to be addressed by large multicenter studies.

Indexed as

Anti-Bacterial AgentsCross InfectionHumansInfant, NewbornInfant, PrematureInfection ControlIntensive Care Units, NeonatalMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsInfection controlMethicillin-resistant Staphylococcus aureusMolecular typingNeonatal infectionsPreterm infants

Identifiers

PMID29804104
PMCPMC6159825
OpenAlexW2804110586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.